COPD Pocket Consultant Guide App for iOS and Android: Support the treatment and management of COPD, therapy chart with the latest medications, inhaler instruction videos, depression and anxiety screeners, a new pulmonary referral checklist and much more
Educational videos and pocasts: Learn about COPD and healthier living : New videos added October 2022
Glossary of COPD words and terms
Encyclopedia of Respiratory Terminology: An interactive tool from John Hopkins School of Medicine
DailyMed Official provider of FDA label information
Causes, Symptoms, & Tips
-
Basic Information
- Breathing Techniques
- Causes and Risk Factors of COPD
- Coping with Everyday Tasks
- Diagnosis & Testing
- Doctor Visits
- Exacerbations & Panic Attacks
- Exercise, & Pulmonary Rehabilitation
- Helpful Organizations & Websites
- Medicines & Devices
- Nutrition
- Supplemental Oxygen, O2 Equipment & Oximeters
- Personal Accounts of Lung Transplant Approvals
- Sleeping Disorders (Tired all the time)
- Stem Cell Article from Jim Nelson
- Surgeries (Transplant, LVRS, BVR, Stents)
- Travel (Including O2 on Airlines)
⭐ COPD Exacerbations: A Patient and Physician’s Perspective John Linnell, John R Hurst November 8, 2019
Suggested Inhaler Sequence — Previous
Suggested Inhaler Sequence — Current
Oxygen Manifesto, Oxygen Manifesto, Part 1: Advice from 3 Respiratory Specialists Noah Greenspan, Mark W Mangus Sr, RRT, RPFT, FAARC, & Oxygen Expert Ryan Diesem Published March 27, 2019
Oxygen Manifesto, Oxygen Manifesto, Part 2: the Devices (Advice from 3 Respiratory Specialists) Noah Greenspan, Mark W Mangus Sr, RRT, RPFT, FAARC, & Oxygen Expert Ryan Diesem Published June 19, 2019
Oxygen Manifesto, Oxygen Manifesto, Part 3: Tips and Tricks from 3 Respiratory Specialists) Noah Greenspan, Mark W Mangus Sr, RRT, RPFT, FAARC, & Oxygen Expert Ryan Diesem Published August 5, 2019
Find a Local Pulmonary Rehabilitation Program LiveBetter.org
The Basics of Pulmonary Rehabilitation from the American Lung Association Last Updated July 13, 2020
American Association of Cardiovascular & Pulmonary Rehabilitation — AACVPR Resources
10 Exercise Myths and Truths: Advice from a Respiratory Specialist Noah Greenspan Published April 12, 2019
Pulmonary Rehab Alternatives Can’t access pulmonary rehabilitation? Wonder what to do after completing pulmonary rehabilitation?
Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) (AERIFY-2) dated Mar 23, 2022, sponsored by Sanofi Study open as of April 09, 2022
Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation (NOTUS) dated Feb 10, 2022, sponsored by Sanofi Study open as of April 09, 2022
🅰 Evaluation of the Safety and Efficacy of TLD in Patients With COPD (AIRFLOW–3) Nuvaira Lung Denervation System (Nuvaira System), Nuvaira’s Targeted Lung Denervation Therapy Shown to Lower Hospitalization Risk and see News “Nuvaira Hopes” dated September 11, 2019, sponsored by Nuvaira, Inc. Study open as of April 09, 2022
⚡ RejuvenAir® System Trial for COPD With Chronic Bronchitis (SPRAY–CB) sponsored by CSA Medical, see also RejuvenAir® Study open as of April 09, 2022
LEEP Losartan Effects on Emphysema Progression LEEP is a randomized clinical trial evaluating the effect of Losartan in helping people with Chronic Obstructive Pulmonary Disease (COPD) with emphysema – a disease of the lungs. We are looking for adults 40 years of age or older, current or former smokers, with COPD to join our study. The study is conducted in different states across the country. Study open as of April 09, 2022
🚬 Insight COPD Intervention Study In Overweight Patients with COPD We are trying to find out if a program proven to help people lose a modest amount of weight and increase their physical activity will improve COPD symptoms for those with a high BMI. To be in the study, you will need to have COPD, high BMI, history of smoking, shortness of breath, and be 40 years or older. Study open as of April 09, 2022
🚬 RETHINC REdefining Therapy IN early COPD The purpose of the RETHINC study is to determine whether symptomatic current and former smokers with normal lung function will benefit from the use of bronchodilator therapy currently used to treat patients who have Chronic Obstructive Pulmonary Disease (COPD). Study open as of April 09, 2022
🧪 Chronic Obstructive Pulmonary Disease Clinical Trials at UCSF 🧪 Trial list upated at least twice a week 🧪 Study open as of April 09, 2022
Emphysema/COPD Research Registry [PA only] Have COPD, 40 and up, 10 year smoking history Study open as of April 09, 2022
Pulmonary Fibrosis Click the link to find many clinical trials avilable offered for Idiopathic Pulmonary Fibrosis, Cystic Fibrosis, Pulmonary Fibrosis by Clinicaltrials.gov Current as of April 09, 2022
COPD Foundation Research Click Research on the main menu
📋 Find a Clinical Trial 📋 American Lung Association 📋
Clinical Trials GPS Find Trials by the US State
Center Watch List Find Trials across the World
ClinicalConnection Find US and International Trials
US NIH ClinicalTrials.gov Searched for trials for COPD, Chronic Obstructive Pulmonary Disease, Lung Disease, Lungs and more
Hospitals Offering Zephyr Valve Treatment
Members Stories on Valve Trials & Treatments
Hospitals Offering Spiration Valve System Treatment
Patient Stories from Spiration Valve System
Medicare, Medicaid and Social Security
Medicare.gov: Find and Compare Information about Hospitals
Getting Assistance: From the Government, Social Services and other Misc Places
COPD Foundation’s Slim Skinny Reference Guide®
Adventures of an Oxyphile 2 Free Audiobook download of the second edition
PulmCCM Free weekly email with latest in pulmonary and critical care
The Pulmonary Paper This is a paid subscription
COPD PPRN Join the COPD Patient–Powered Research Network to help move COPD research forward
Members Personal Pages and Profiles
Q & A Oxygen Equipment (Pete’s Posts)
Q & A Medical: Drs Karpick, Yeager and Petty
Q & A Respiratory Therapy/Specialists